Tekrardan Hoşgeldiniz
Cointime'ın Hizmet Şartları'ini kabul etmek ve Cointime'ın Gizlilik Politikası'inin sizin için geçerli olduğunu onaylamak için "Giriş "a tıklayın.
Cointime’a Katıl
Çoktan Hesabın Var mı?
Cointime'ın <a class="underline" href="#term-of-service">Hizmet Şartları</a>'ini kabul etmek ve Cointime'ın a class="underline" href="#privacy-policy">Gizlilik Politikası</a>'inin sizin için geçerli olduğunu onaylamak için "page.Sign up "a tıklayın.
Giriş Yap
Kayıt Ol
Posta kutunuz
Gelen kutunuzu kontrol edin
Giriş yapmak için emaildeki bağlantıya tıklayın.
Kayıt olmak için emaildeki bağlantıya tıklayın.
Chronus Health
company
About
Chronus Health is a portable platform that enables doctors to provide real-time treatment based on actual lab results.
- 1 - 10
Highlights
Details
- Last Funding Type
- Series A
- Last Funding Money Raised
- $22M
- Industries
- Health Care,Medical Device,Real Time
- Founded date
- Jan 1, 2017
- Number Of Employee
- 1 - 10
- Operating Status
- Active
Chronus Health is a portable platform that enables doctors to provide real-time treatment based on actual lab results. The company developing a portable CLIA waived system to deliver point-of-care lab results in minutes. It allows for real-time diagnosis at the point-of-care providing lab results in minutes, dramatically improving patient outcomes. Chronus Health was founded in 2017 and is headquartered in Mountain View, California, United States.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$22M
Chronus Health has raised a total of
$22M
in funding over 2 rounds. Their latest funding was raised on
Jan 12, 2022 from a Series A round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jan 12, 2022 | Series A | $22M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
Chronus Health is funded by 1 investors.
Savantus Ventures
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Savantus Ventures
|
— | Series A |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
